Istanbul Medipol University
Istanbul, Fatih, Turkey (Türkiye)
NCT Number: NCT06583226
An epithelialized gingival graft will be harvested from the palate for the treatment of various mucogingival deformities. The donor site will be treated with either a combination of a collagen sponge, cyanoacrylate and suspending sutures or a collagen sponge, cyanoacrylate, suspending sutures and coconut oil.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Istanbul, Fatih, Turkey (Türkiye)
After epithelialized gingival graft harvesting, intraoperatively, measurements will be taken for palatal tissue thickness, graft dimensions, working time, and primary bleeding time. Data regarding pain perception will be gauged using a visual analog scale, and the number of analgesics, secondary bleeding, epithelization level, and color match will be assessed prospectively. These outcomes will be evaluated on the first 7 days and subsequently on the 14th, 21st, and 28th days. Patient-reported outcomes will be recorded using the Oral Health Impact Profile-14 questionnaire.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
age ≥18; mucogingival surgical treatment indication that needs connective tissue graft in the anterior mandible; stable periodontium after phase I therapy; full-mouth plaque and bleeding scores <15%
Exclusion criteria
The donor site will be closed both with gelatin sponge +Cyanoacrylate (Spongostan®, Ethicon, USA)+ supporting sutures (control group)
Seconder The donor site will be closed both with gelatin sponge +Cyanoacrylate (Spongostan®, USA) and coconut oil (test group)
Time frame: everyday in first week
Patients score their daily donor site pain perception using visual analog score level by giving numbers from 0 to 10 according to the visual analog scale (0: no pain, 1: minimal pain, 10: severe pain)
Time frame: during first week
Patients will record presence or absence of secondary bleeding (presence=1 or absence=0).
Time frame: during surgery
Dimensions will be measured during surgery by clinician using Michigan O probe (will be reported in mm)
Time frame: during surgery
Dimensions will be measured during surgery by clinician using Michigan O probe.(will be reported in mm)
Time frame: during surgery
Dimensions will be measured during surgery by clinician using Michigan O probe (will be reported in mm)
Time frame: during surgery
Harvesting process will be recorded by an blinded research assistant
Time frame: first week
Patients recorded the quantity of analgesics taken will be reported as quantity of pill
Time frame: first week, second week , third week, fourth week.
Sensation loss will be scored by the help of clinician comparing with the symmetrical side an will be recorded as no-loss, medium loss or severe loss
Time frame: first week, second week, third week, fourth week.
Color match with the adjacent tissue was determined by researcher using a Visual Analog Pain Scale scale (0: absence of harmony, 10: excellent harmony)
Time frame: first week, second week, third week, fourth week.
Epithelization level was scored by researcher as none, partial or full epithelization by means of bubble formation after dripping hydrogen peroxide (3%) to the wound surface
Time frame: first week
The questionnaire has 14 items with answers rated on a 5-point Likert scale (from 1 = never to 5 = very often) to indicate a level of different problems related to oral health
Medipol University
Other
The Effect of Two Different Approaches on Palatal Donor Site Management After De-epithelialized Graft Harvesting: Randomized Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05510362
Infections, Opportunistic Infections
Monastir, Monastir Governorate, Tunisia
View Trial DetailsNCT05579743
Cardiovascular Diseases, Diabetes Complications
Baltimore, Maryland, United States
View Trial DetailsNCT04618406
Amputation, Cardiovascular Diseases
Aabenraa, Denmark
View Trial DetailsNCT05074212
Wound Heal, Wound of Skin
Sacramento, California, United States
View Trial Details